SCHEMBL6797401

SCHEMBL6797401

CC(C)(C)OC(=O)[C@@H](O)CCN

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 2/20 0.36
NOS3 P29474 1/20 0.36
NOS2 P35228 1/20 0.36
GABRR1 P24046 2/20 0.35
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
CPB2 Q96IY4 1/20 0.33
CTSK P43235 5/20 0.32
AAK1 Q2M2I8 1/20 0.32
LMNA P02545 1/20 0.31
CYP2D6 P10635 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
DGAT1 O75907 1/20 0.30
GABBR2 O75899 1/20 0.30
GABBR1 Q9UBS5 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7110422 1.00 NOS1 (0.36) NOS1NOS3NOS2GABRR1KMT2A
SCHEMBL9417498 0.91 CA12 (0.34) NOS1NOS3NOS2GABRR1KMT2A
SCHEMBL2177004 0.88 CPB2 (0.38) NOS1NOS3NOS2KMT2AMEN1
SCHEMBL133019 0.86 CPB2 (0.44) NOS1NOS3NOS2KMT2AMEN1
SCHEMBL2567893 0.85 CPB2 (0.46) NOS1NOS3NOS2KMT2AMEN1
SCHEMBL6799320 0.83 NOS1 (0.35) NOS1NOS3NOS2GABRR1KMT2A
SCHEMBL5667907 0.83 NOS1 (0.35) NOS1NOS3NOS2GABRR1KMT2A
Methylamine SCHEMBL28388761 0.82 NOS1 (0.39) NOS1NOS3NOS2KMT2AMEN1
SCHEMBL28058283 0.82 KMT2A (0.36) NOS1NOS3NOS2GABRR1KMT2A
SCHEMBL9242626 0.81 GPR84 (0.42) NOS1NOS3NOS2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119913220-A Method for preparing GLP-1 receptor agonist intermediate 宁波酶赛生物工程有限公司 2025-05-02 CN disclosed
US-6750219-B1 HAVING INTEGRIN ALPHA V BETA 3 ANTAGONISTIC ACTIVITY, GP IIB/IIIA ANTAGONISTIC ACTIVITY, AND/OR HUMAN PLATELET AGGREGATION INHIBITORY ACTIVITY AND ALSO HAVING EXCELLENT WATER SOLUBILITY MEIJI SEIKA KAISHA, LTD. (JP) 2004-06-15 US disclosed
EP-1209152-A1 OMEGA-AMINO-ALPHA-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN ALPHA V BETA 3 ANTAGONISM MEIJI SEIKA KAISHA LTD. (JP) 2002-05-29 EP disclosed